2025 ICD-10-CM code E31.2
Multiple endocrine neoplasia (MEN) syndromes. This code encompasses multiple endocrine adenomatosis and associated malignancies and other conditions.
Medical necessity for procedures and treatments related to MEN syndromes must be clearly documented. This includes demonstrating the presence of functional tumors, hormonal imbalances, and the clinical impact of these conditions on the patient's health.Specific payer guidelines should be consulted.
Diagnosis and treatment of MEN syndromes often requires a multidisciplinary approach involving endocrinologists, geneticists, surgeons, and other specialists depending on the affected glands.Diagnosis may involve genetic testing, blood and urine hormone level measurements, and imaging studies like CT and MRI scans to locate tumors. Treatment options typically include surgery to remove tumors or affected glands, and medications to control hormone levels.
- 4: Endocrine, Nutritional and Metabolic Diseases (E00-E89)
- E31: Multiple endocrine neoplasia syndromes
In simple words: Multiple endocrine neoplasia (MEN) syndromes are inherited conditions where tumors grow in several hormone-producing glands in your body. These tumors can make extra hormones, leading to different health problems.There are different types of MEN, like MEN 1, MEN 2A, and MEN 2B. Each type affects different glands. For example, MEN 1 often involves the glands in your neck (parathyroid and thyroid) that control calcium levels, the gland in your belly (pancreas) that helps with digestion, and the gland in your brain (pituitary) that controls many other hormones.
Multiple endocrine neoplasia (MEN) syndromes are a group of inherited disorders characterized by tumors or excessive growth in multiple endocrine glands. These glands produce hormones, and the tumors can lead to overproduction of these hormones, causing various symptoms.The most common types are MEN 1, MEN 2A, and MEN 2B, each affecting different combinations of glands. MEN 1 typically involves the parathyroid, pancreas, and pituitary glands. MEN 2A affects the thyroid, adrenal glands, and sometimes the parathyroids. MEN 2B involves the thyroid, adrenal glands, and mucosal neuromas.
Example 1: A patient presents with hypercalcemia, kidney stones, and peptic ulcers.Further testing reveals tumors in the parathyroid glands and pancreas. Genetic testing confirms a diagnosis of MEN 1., An infant is diagnosed with medullary thyroid cancer. Genetic testing reveals a mutation in the RET gene, and the diagnosis is MEN 2B.The patient also exhibits mucosal neuromas., A patient experiences episodes of severe hypertension, headaches, and sweating. Imaging studies reveal an adrenal tumor (pheochromocytoma). Further evaluation identifies medullary thyroid cancer, leading to a diagnosis of MEN 2A.
Thorough documentation of family history, signs and symptoms, laboratory results (hormone levels, genetic testing), imaging findings, and treatment procedures is crucial for accurate coding and optimal patient management.
- Specialties:Endocrinology, Oncology, Genetics, General Surgery
- Place of Service:Inpatient Hospital, Outpatient Hospital, Physician's Office